{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:06:32Z","timestamp":1774566392608,"version":"3.50.1"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"DOI":"10.1038\/s41433-026-04340-4","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:39:20Z","timestamp":1771576760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-induced corneal oedema: amantadine-associated toxicity"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0619-3512","authenticated-orcid":false,"given":"Kelly Ann","family":"Hutchinson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-4437","authenticated-orcid":false,"given":"Susan","family":"Mollan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"4340_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12886-022-02410-1","volume":"22","author":"M Cennamo","year":"2022","unstructured":"Cennamo M, Dragotto F, Favuzza E, Morelli A, Mencucci R. Amantadine therapy for Parkinson\u2019s Disease: in vivo confocal microscopy corneal findings, case report and revision of literature. BMC Ophthalmol. 2022;22:1\u20135. https:\/\/doi.org\/10.1186\/s12886-022-02410-1.","journal-title":"BMC Ophthalmol"},{"key":"4340_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1097\/ICO.0b013e318180e526","volume":"27","author":"KC Chang","year":"2008","unstructured":"Chang KC, Mee KK, Won RW, Lee JH. Corneal endothelial dysfunction associated with amantadine toxicity. Cornea. 2008;27:1182\u20135.","journal-title":"Cornea"},{"key":"4340_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/jop.2009.0029","volume":"25","author":"S Esquenazi","year":"2009","unstructured":"Esquenazi S. Bilateral reversible corneal edema associated with amantadine use. J Ocul Pharmacol Ther. 2009;25:567\u20139. https:\/\/doi.org\/10.1089\/jop.2009.0029.","journal-title":"J Ocul Pharmacol Ther"},{"key":"4340_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-98005-9","volume":"11","author":"PY Lee","year":"2021","unstructured":"Lee PY, Lai YH, Liu PL, Liu CC, Su CC, Chiu FY, et al. Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells. Sci Rep. 2021;11:1\u201311. https:\/\/doi.org\/10.1038\/s41598-021-98005-9.","journal-title":"Sci Rep"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04340-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04340-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04340-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:39:20Z","timestamp":1771576760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04340-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":4,"alternative-id":["4340"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04340-4","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SM reports consultancy fees (Invex Therapeutics); advisory board fees (Ocular Therapeutix, Domp\u00e9 Farmaceutici); speaker fees (Teva); Travel (AbbVie, EssilorLuxottica and European Alliance of Associations for Rheumatology); Receipt of equipment (Heidelberg Engineering). SM is a member of the\n                      Eye\n                      editorial board. The other authors declare no potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed written consent was obtained from the patient for the publication of this case and images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}